Breast Cancer Risk via Cell Squeezing Technology

Key Highlights

• Novel cell-squeezing technology assesses breast cancer risk at the cellular level.
• Microfluidic platform measures cell deformation and recovery under stress.
• Machine learning assigns individualized breast cancer risk scores.
• Introduces the concept of “mechanical age” of cells linked to cancer risk.
• A scalable, low-cost design may support broader population-level screening.
• For More Updates on Breast Cancer and women’s health, register for #HerHealth2026

Why Breast Cancer Risk Assessment Needs Innovation

Breast cancer risk assessment remains limited for the majority of women without known genetic mutations. Traditional models rely on population-based estimates or imaging tools like mammography, which detect disease only after tumor formation.

Researchers from City of Hope and the University of California, Berkeley have introduced a novel microfluidic platform designed to directly analyze breast epithelial cells. This cell squeezing technology for cancer risk assessment provides a new method to quantify risk based on cellular behavior rather than indirect predictors.

Non-Genetic Breast Cancer Risk Assessment

With over 90% of women lacking identifiable genetic risk factors, this approach addresses a significant clinical gap. It offers clinicians measurable, patient-specific data derived directly from cell mechanics.

How Cell Squeezing Technology Measures Breast Cancer Risk

The platform uses a microfluidic system that forces individual cells through narrow channels, creating mechanical stress. Researchers then evaluate how cells deform and recover, critical indicators of cellular health and aging.

Mechanical Age of Cells in Cancer Risk

This process introduces the concept of mechanical age, reflecting how cells respond physically to stress. Cells with higher mechanical age demonstrate stiffness and delayed recovery, both associated with increased cancer risk.

The system applies mechano-node-pore sensing, where electrical currents detect changes in cell size and shape during passage through fluid-filled channels. Machine learning algorithms analyze these parameters to generate a personalized risk score.

Notably, the study found that some younger women exhibited cell behaviors similar to older individuals. These cases often correlated with known genetic mutations, validating the platform’s predictive capability.

Clinical Implications: Scalable and Personalized Screening

Machine Learning Breast Cancer Risk Prediction

The integration of machine learning enables precise differentiation between low-risk and high-risk individuals. Unlike traditional imaging, this method identifies risk before tumor development, supporting earlier surveillance strategies.

Importantly, the platform relies on simple electronics comparable to consumer devices, making it cost-effective and scalable. This design could facilitate widespread adoption across clinical settings, including resource-limited environments.

Explore All Oncology CME Conferences and Online Courses 2026

For healthcare professionals, this innovation introduces a potential shift toward cell-based diagnostics, allowing more accurate screening decisions and reducing both over-screening and missed diagnoses.

Source:

City of Hope